Literature DB >> 12807390

Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery.

Gun-Marie Hariz1, Margareta Lindberg, Marwan I Hariz, A Tommy Bergenheim.   

Abstract

OBJECTIVES: To investigate eventual differences between women and men with Parkinson's disease (PD) before and after surgery, with respect to clinical status, disability and health-related quality of life (HRQoL).
MATERIAL AND METHODS: Twenty-four men and 14 women with PD received a total of 46 surgical procedures (pallidotomy, thalamotomy and deep brain stimulation of the thalamus, pallidum or subthalamic nucleus). The impact of PD on disability and other aspects of HRQoL was analysed separately in men and women before and at a mean of 11 months after surgery, using the following assessment tools: The Unified Parkinson's Disease Rating Scale (UPDRS), the ADL Taxonomy, the Nottingham Health Profile, the Life Satisfaction Questionnaire and a Visual Analogue Scale.
RESULTS: At surgery, women had a significantly longer duration of disease than men (mean: 15 vs. 10 years, P < 0.01). They had a higher stage on the Hoehn and Yahr scale and worse scores on UPDRS parts II (ADL) and IV (complications), as well as on the Schwab and England scale and on the ADL Taxonomy. Following surgery, both men and women showed improvement, but women experienced greater benefit than men in ADL, in emotions, and in social life.
CONCLUSIONS: Perhaps women with PD should be offered surgery more often and earlier in the course of their disease.

Entities:  

Mesh:

Year:  2003        PMID: 12807390     DOI: 10.1034/j.1600-0404.2003.00092.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  28 in total

Review 1.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

Review 2.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

3.  Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion.

Authors:  Fatemeh Mohagheghi; Leila Khalaj; Abolhassan Ahmadiani; Behrouz Rahmani
Journal:  Neurotox Res       Date:  2012-07-07       Impact factor: 3.911

4.  Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.

Authors:  Katia Noyes; Andrew W Dick; Robert G Holloway
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 6.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

Review 7.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

8.  Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation.

Authors:  Luigi Michele Romito; Fiorella Maria Contarino; Alberto Albanese
Journal:  J Neurol       Date:  2009-11-18       Impact factor: 4.849

9.  Gemfibrozil pretreatment resulted in a sexually dimorphic outcome in the rat models of global cerebral ischemia-reperfusion via modulation of mitochondrial pro-survival and apoptotic cell death factors as well as MAPKs.

Authors:  Fatemeh Mohagheghi; Abolhassan Ahmadiani; Behrouz Rahmani; Fatemeh Moradi; Nathalie Romond; Leila Khalaj
Journal:  J Mol Neurosci       Date:  2013-01-05       Impact factor: 3.444

10.  A theoretical model for analysing gender bias in medicine.

Authors:  Gunilla Risberg; Eva E Johansson; Katarina Hamberg
Journal:  Int J Equity Health       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.